LYFE-3R

LYFE-3R has been found to target three receptors: GLP-1, GIP, and glucagon. Clinical trials show it can lead to possibly supporting appetite regulations, healthy weight management pathways and may improve metabolic efficiency and could balance blood sugar mechanisms. 

This is a synthetic peptide supplied for qualified laboratory research use only. This material is intended for analytical characterization, assay development, method validation, and other non-clinical research applications conducted by properly trained professionals in controlled settings.

COA: Product information is provided for compound identification and laboratory reference purposes only. Any use must be limited to lawful research activities and handled in accordance with applicable institutional, regulatory, and safety requirements.

RUO: This material is supplied strictly for research use only and is not intended for human or veterinary use, diagnostic use, therapeutic use, or food use.